Cefoperazone was compared with clindamycin plus gentamicin for the treatment of pelvic infections. Of 102 women, 95 (93%) demonstrated a good clinical response (47 with cefoperazone and 48 with clindamycin plus gentamicin). Of the seven failures, four were secondary to side effects and three were clinical failures.
Cefoperazone provides broad-spectrum coverage against many of the organisms encountered in obstetric and gynecologic infections (2, 8, 11, 13) . The present study was undertaken to compare cefoperazone with clindamycin plus gentamicin for the treatment of women with pelvic infections (postpartum endometritis, posthysterectomy vaginal cuff infections, or acute pelvic inflammatory disease). Reasons for exclusion included breast-feeding, pregnancy, and hypersensitivity to penicillin. The clinical diagnosis of pelvic infection was based primarily on the presence of fever, pain, and leukocytosis. Specifically, patients with salpingitis had cervical motion and adnexal tenderness or an adnexal mass or both. Patients with endometritis had uterine and parametrial tenderness and foul lochia. Patients with posthysterectomy cellulitis had exceptional tenderness and induration of the vaginal cuff.
Cultures had been obtained from all patients before therapy. For women with endometritis, specimens were obtained from endometrial washings (7) . For women with posthysterectomy cuff cellulitis, specimens were obtained by direct sampling of the vaginal cuff. Women with acute salpingitis had specimens taken via culdocentesis for aerobic and anaerobic organisms, as well as Neisseria gonorrhoeae, and directly from the endocervix for isolation of N. gonorrhoeae. Specimens for isolation of the gonococcus were plated directly onto Thayer-Martin medium, whereas all others were transported to the laboratory in a Port-A-Cul (BBL Microbiology Systems) vial or tube. Techniques for isolation and identification of aerobic and anaerobic organisms have been previously described (9, 10, 12, 15 (6) 6 (100) 6 (100) NT Fusobacterium species (8) 8 (100) 8 (100) NT Eubacterium species (3) 3 (100) gentamicin therapy with a good clinical response. The remaining clinical failure was in the clindamycin-gentamicin group (postcesarean section endometritis), and no resistant organisms were isolated. This patient responded favorably to the addition of ampicillin. Six patients in the cefoperazone group and two patients in the clindamycin-gentamicin group had transient minimal elevations of glutamic-oxaloacetic transaminase in serum. In addition, one patient in the cefoperazone group had an unexplained transient elevation of the eosinophil count while on therapy, and two patients in the clindamycin-gentamicin group had an elevated serum creatinine or blood urea nitrogen level. Because of the inherent risks with regimens consisting of combinations of antibiotics, single-agent therapy would be preferred provided that the individual antibiotics were successful (i.e., had a high cure rate) in most pelvic infections treated. Fortunately, most newer cephalosporins and penicillins do provide a wide spectrum of coverage and have been reported to be quite efficacious as well as relatively safe for the patient (3-6, 9, 14, 17) . The major drawback with these newer antibiotics is cost. In the present study, cefoperazone was both safe and efficacious for treating women with polymicrobial pelvic infections. Although this study included only 102 patients, cefoperazone appeared to be as effective as clindamycin-gentamicin, although a type II error cannot be ruled out. Moreover, side effects were infrequent and generally minor in nature. In addition, most organisms tested with the antibiotic were susceptible to clinically achievable levels.
